4-((5-fluoro-4-(phenylamino)pyrimidin-2-yl)amino)benzamide

ID: ALA5278077

Chembl Id: CHEMBL5278077

Max Phase: Preclinical

Molecular Formula: C17H14FN5O

Molecular Weight: 323.33

Associated Items:

Names and Identifiers

Canonical SMILES:  NC(=O)c1ccc(Nc2ncc(F)c(Nc3ccccc3)n2)cc1

Standard InChI:  InChI=1S/C17H14FN5O/c18-14-10-20-17(22-13-8-6-11(7-9-13)15(19)24)23-16(14)21-12-4-2-1-3-5-12/h1-10H,(H2,19,24)(H2,20,21,22,23)

Standard InChI Key:  IBAUSYCHSXHDOA-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5278077

    ---

Associated Targets(Human)

AURKA Tchem Serine/threonine-protein kinase Aurora-A (10240 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AURKB Tchem Serine/threonine-protein kinase Aurora-B (6805 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JAK2 Tclin Tyrosine-protein kinase JAK2 (12915 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 323.33Molecular Weight (Monoisotopic): 323.1182AlogP: 3.20#Rotatable Bonds: 5
Polar Surface Area: 92.93Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 12.96CX Basic pKa: 1.83CX LogP: 3.20CX LogD: 3.20
Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.67Np Likeness Score: -1.45

References

1. Liu M, Ju X, Zou J, Shi J, Jia G..  (2020)  Recent researches for dual Aurora target inhibitors in antitumor field.,  203  [PMID:32693295] [10.1016/j.ejmech.2020.112498]

Source